OneTouch Verio

Johnson and Johnson RCT aims to find out if a diabetes app can improve A1C
By Jonah Comstock | 10:56 am | May 04, 2015
Johnson & Johnson company LifeScan is launching a clinical trial to determine whether its OneTouch Verio blood glucose meter (or a not-yet-launched version of it) creates a greater reduction in A1C levels when used in conjunction with its companion app.